Zheng, T., Li, D., He, Z., & Zhao, S. (2019). miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int.
Dyfyniad Arddull ChicagoZheng, Tian-Liang, De-Ping Li, Zhan-Feng He, and Song Zhao. "MiR-145 Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin Through Directly Inhibiting PI3K/AKT Signaling Pathway." Cancer Cell Int 2019.
Dyfyniad MLAZheng, Tian-Liang, De-Ping Li, Zhan-Feng He, and Song Zhao. "MiR-145 Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin Through Directly Inhibiting PI3K/AKT Signaling Pathway." Cancer Cell Int 2019.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.